Introduction: Septic patients undergoing mechanical ventilation (MV) often experience difficulty in weaning. Th aim of this study was to determine whether inflammatory biomarkers of sepsis could be indicative of the failure or success of spontaneous breathing trial (SBT) in these patients. Methods: Sixty-five patients on MV (42 septic and 23 intubated for other reasons) fulfilling the criteria for SBT were included in the study. Blood samples were collected right before, at the end of (30 min) and 24 h after the SBT. Serum inflammatory mediators associated with sepsis (IL-18, IL-18BP, TNF) were determined and correlated with the outcome of SBT. Results: A successful SBT was achieved in 45 patients (69.2%). Septic patients had a higher percentage of SBT failure as compared to non-septic patients (85% vs. 15%, p = 0.026), with an odds ratio for failing 4.5 times (OR = 4.5 95%CI: 1.16–17.68, p 0.022). IL-18 levels and the relative mRNA expression in serum were significantly higher in septic as compared to non-septic patients (p < 0.05). Sepsis was independently associated with higher serum IL-18 and TNF levels in two time-point GEE models (53–723, p = 0.023 and 0.3–64, p = 0.048, respectively). IL-18BP displayed independent negative association with rapid shallow breathing index (RSBI) (95% CI: −17.6 to −4, p = 0.002). Conclusion: Sustained increased levels of IL-18 and IL-18BP, acknowledged markers of sepsis, were found to be indicative of SBT failure in patients recovering from sepsis. Our results show that, although subclinical, remaining septic inflammation that sustaines for a long time complicates the weaning procedure. Biomarkers for the estimation of the septic burden and the right time for weaning are needed.
23 April 2025 in Respiratory Medicine Case Reports
Melanomas are skin derived malignant tumors exhibiting extreme diversity during disease progression in terms of time and site of metastasis. This is a rare case of a 68 year old, former smoker male, with a history of a cutaneous head melanoma which was treated 20 years ago. He presented with dyspnea and mild hemoptysis. On examination a solid mass found at the right lower lobe. Bronchoscopy performed and biopsies taken revealing endobronchial metastatic melanoma. Tissue genomics revealed two rare mutations. Finally patient received a doublet of immunotherapy and targeted therapy regiments. To the best of our knowledge this is a rare case of endobronchial metastasis 20 years after the treatment of the primary site. After so many years elapsed it is difficult to make a differential diagnosis between metastasis and a second primary endobronchial melanoma. Surgery and bronchoscopic modalities are promising only if they can be combined with immunotherapy and targeted therapies which are the game changers regarding the treatment of the disease.
Background/Objectives: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) can cause respiratory symptoms and physiological impairment. We explored whether quantitative somatostatin-receptor imaging by positron emission tomography/computed tomography with gallium-68-labelled DOTATOC (68Ga-DOTATOC PET/CT) is associated with pulmonary physiology and nodule count in histologically confirmed DIPNECH. Methods: This retrospective, single-centre, hypothesis-generating series included six consecutive adults diagnosed during 2020–2025. Spearman correlations with exact permutation p-values and 95% confidence intervals related the maximum standardised uptake value (SUVmax) of the most avid lesion to diffusing capacity for carbon monoxide (DLCO), forced expiratory flow between 25% and 75% of forced vital capacity (FEF25–75) and the ratio of forced expiratory volume in 1 s to forced vital capacity (FEV1/FVC); index-lesion diameter and expected partial-volume recovery were examined. Analyses were exploratory and unadjusted for multiple comparisons. Results: All patients were women. SUVmax correlated inversely with DLCO (ρ = −0.90; p = 0.028) and FEF25–75 (ρ = −0.84; p = 0.044); the nodule-count–DLCO association was uncertain (ρ = −0.37; p = 0.50). Index lesions measured 3.6–4.7 mm, below the resolution of the PET system; lesion diameter was unrelated to SUVmax (ρ = −0.20), and the association with DLCO persisted after crude recovery correction (ρ = −0.66). Conclusions: Higher 68Ga-DOTATOC uptake of the most avid lesion accompanied greater physiological impairment in this six-patient series, and the differences in uptake were not explained by lesion size. Given the sample size, wide confidence intervals, multiple unadjusted comparisons, unadjusted comorbidities and sub-resolution lesions, these findings are hypothesis-generating only; they do not establish SUVmax as a marker of disease severity, an actionable threshold or a guide to biopsy, but support prospective investigation of somatostatin-receptor imaging in DIPNECH.
Background/Objectives: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) can cause respiratory symptoms and physiological impairment. We explored associations between quantitative ⁶⁸Ga-DOTATOC uptake, pulmonary physiology and nodule count in histologically confirmed DIPNECH. Methods: This retrospective single-centre series included six consecutive adults diagnosed during 2020–2025 who underwent ⁶⁸Ga-DOTATOC PET/CT. Histological confirmation was obtained by surgical lung biopsy in four patients and transbronchial cryobiopsy in two. Spearman correlations assessed associations of maximum standardised uptake value (SUVmax) with pulmonary-function measures and a post hoc composite index incorporating diffusing capacity for carbon monoxide (DLCO), FEF25–75 and FEV1/FVC. Nodule count was compared with DLCO. Analyses were exploratory, without adjustment for multiple comparisons. Results: All patients were women (mean age, 70.3 ± 8.9 years). SUVmax correlated inversely with DLCO (ρ = −0.90; p = 0.015) and FEF25–75 (ρ = −0.84; p = 0.036), and positively with the composite index (ρ = +0.90; p = 0.015). The nodule-count–DLCO association was uncertain (ρ = −0.37; p = 0.47). A post hoc SUVmax split at approximately 4 identified groups with different mean physiological measurements but was not evaluated as a diagnostic threshold. Conclusions: Higher DOTATOC uptake was associated with greater physiological impairment in this selected six-patient series. The findings support prospective investigation of somatostatin-receptor imaging in DIPNECH. They do not establish superiority over nodule counting, an actionable SUVmax threshold or a preferred biopsy strategy.
Endobronchial lipomas are rare benign tumours that can cause airway obstruction and recurrent infection. A 70‐year‐old smoker with combined pulmonary fibrosis and emphysema presented with recurrent right middle lobe infections and declining pulmonary function. Computed tomography revealed a fat‐density lesion obstructing the middle lobe bronchus, with atelectasis and consolidation. Bronchoscopy and histology confirmed lipoma. Given limited respiratory reserve, lung‐sparing flexible bronchoscopy with snare electrocautery and argon plasma coagulation restored airway patency; retained purulent secretions were drained and infection treated. At 2 months, the patient was asymptomatic with radiological resolution; FVC improved from 75% to 83% predicted and DLCO from 35% to 50% predicted. Recovery followed concurrent recanalization, drainage and antimicrobial treatment, whose individual contributions cannot be separated. This case highlights bronchoscopic diagnosis and treatment of benign obstruction in persistent middle lobe disease. Longer surveillance is needed to assess durability.